UBE2V1 and acute myeloid leukemia: There were 104 normal and acute myeloid leukemia (42 populations and 62 leukemic populations) samples included in GSE63270 dataset, we compared the abundance of UBE2N+NK-C1, UBE2V1+NK-C2, DYNC1H1+NK-C3, PARK7+NK-C4, TUBA1B+CD8+ T−C1, DYNC1H1+CD8+ T−C2, UBE2V1+CD8+ T−C3, UBE2N+CD8+ T−C4, DYNLL1+Mac-C1, UBE2V1+Mac-C2, TUBA1A+Mac-C3, and PAPK7+Mac-C4 between normal and AML samples (Figure 5A).